Mexico Neurovascular Devices Market Size & Outlook
Mexico neurovascular devices market, 2018-2030 (US$M)
Related Markets
Mexico neurovascular devices market highlights
- The Mexico neurovascular devices market generated a revenue of USD 99.4 million in 2023 and is expected to reach USD 146.8 million by 2030.
- The Mexico market is expected to grow at a CAGR of 5.7% from 2024 to 2030.
- In terms of segment, cerebral embolization and aneurysm coiling devices was the largest revenue generating device in 2023.
- Neurothrombectomy Devices is the most lucrative device segment registering the fastest growth during the forecast period.
Neurovascular devices market data book summary
| Market revenue in 2023 | USD 99.4 million |
| Market revenue in 2030 | USD 146.8 million |
| Growth rate | 5.7% (CAGR from 2023 to 2030) |
| Largest segment | Cerebral embolization and aneurysm coiling devices |
| Fastest growing segment | Neurothrombectomy Devices |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cerebral Embolization and aneurysm Coiling devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Trans Radial Access Devices |
| Key market players worldwide | Medtronic PLC, Johnson & Johnson, Penumbra Inc, MicroPort Scientific Corp, Stryker Corp, Terumo Corp, Integra Lifesciences Holdings Corp |
Other key industry trends
- In terms of revenue, Mexico accounted for 3.3% of the global neurovascular devices market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Argentina neurovascular devices market is projected to lead the regional market in terms of revenue in 2030.
- Argentina is the fastest growing regional market in Latin America and is projected to reach USD 219.5 million by 2030.
Cerebral embolization and aneurysm coiling devices was the largest segment with a revenue share of 35.21% in 2023. Horizon Databook has segmented the Mexico neurovascular devices market based on cerebral embolization and aneurysm coiling devices, cerebral angioplasty and stenting systems, neurothrombectomy devices, support devices, trans radial access devices covering the revenue growth of each sub-segment from 2018 to 2030.
Mexico's neurovascular devices market is anticipated to witness low-slung growth over the forecast period. The rising geriatric population is anticipated to fuel the market at a moderate pace in this country.
For instance, according to the World Data Atlas, in 2020, the population aged 65 years and above for Mexico was 7.6 %. Over the past 50 years, Mexico’s population aged 65 years and above grew substantially from 3.8% to 7.6%, rising at a cumulative annual rate that reached a maximum of 2.72% in 2020.
As the geriatric population is at a higher risk of neurological diseases, such as stroke, trauma, meningitis, migraine and others, this factor is likely to fuel market growth in coming years. Moreover, a lack of skilled professionals and less knowledge regarding the treatment of acute ischemic stroke are among the factors expected to impede market growth.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Neurovascular Devices Market Scope
Neurovascular Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Mexico neurovascular devices market size, by device, 2018-2030 (US$M)
Mexico Neurovascular Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
